John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He explains how this treatment has shown exceptional efficacy with limited side effects.
Jennifer Silva, APRN-DNP: Providing Adequate Treatment for Patients with Vitiligo
Jennifer Silva discusses a few treatment strategies to utilize in patients who continue to struggle to find effective treatment for their vitiligo.
PLAY
Iltefat Hamzavi, MD: Combining Phototherapy with Topical Therapy in Patients with Vitiligo
Iltefat Hamzavi, MD, and JCAD’s Editor-in-Chief, James Del Rosso, DO, discuss topical treatment considerations for patients with vitiligo when using topical ruxolitinib cream, including topical...
PLAY
Gina Mangin, MPAS, PA-C: Coaching Pearls for Patients with Vitiligo
Gina Mangin discusses effective treatment practice for patients with vitiligo centered around providing encouragement and motivation throughout the process.
PLAY
David Rosmarin, MD: Updates in Topical and Systemic Vitiligo Treatment
Dr. Rosmarin discusses his vitiligo session from November’s Masterclasses in Dermatology Meeting, in which he reviewed recent insights on maintaining and building upon initial treatment...
PLAY
Gina Mangin, MPAS, PA-C: Using Light Box Therapy for Patients with Vitiligo
Gina Mangin discusses the importance of educating patients on the expected timeline for repigmentation when utilizing light box therapy.
PLAY
Shanna Miranti, MPAS, PA-C: Prescribing Ruxolitinib for Patients with Vitiligo
Shanna Miranti speaks to the importance of trying and failing with topical corticosteroids and topical calcineurin inhibitors prior to prescribing patients with topical ruxolitinib.
PLAY